Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Depsipeptide in Treating Patients With Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating depsipeptide (romidepsin) in lymphoma patients has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia [Phase 1]
Phase 1 study evaluating UCN-01 in combination with fludarabine for recurrent or refractory leukemia or lymphoma; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Flavopiridol in Treating Patients With Refractory Cancer [Phase 1]
This clinical trial update reports on a Phase 1 study of flavopiridol in patients with refractory cancers, including lymphoma, prostate canc…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma [Phase 1]
The entry details the completion of a Phase 1 trial evaluating Bryostatin 1 in combination with Interleukin-2 in patients with refractory so…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Immunotoxin in Treating Patients With Leukemia or Lymphoma [Phase 1]
This is a Phase 1 clinical trial update describing an immunotoxin used to treat leukemia or lymphoma. The study status is completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Arsenic Trioxide in Treating Young Patients With Refractory Leukemia or Lymphoma [Phase 1]
A Phase 1 study sponsored by the National Cancer Institute evaluating arsenic trioxide in pediatric patients with refractory leukemia or lym…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer [Phase 1]
A Phase 1 study evaluating perifosine in patients with refractory solid tumors and hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [Phase 2]
Phase 2 trial of unrelated donor transplantation for malignant and non-malignant hematologic disorders; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Study of Bortezomib in Combination With Cyclophosphamide and Rituximab [Phase 2]
Phase 2 study of bortezomib in combination with cyclophosphamide and rituximab in mantle cell lymphoma and other lymphomas has completed wit…
-
CLINICAL_TRIALS trial_result · 2015-04-13Clinical Trial Update: Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies [Phase 1]
Open-label Phase 1 dose-escalation study of 4SC-205, an Eg5 kinesin-spindle inhibitor, in patients with advanced solid tumors and malignant …
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas [Phase 1]
Phase 1 clinical trial update of Aneustat (OMN54) in patients with advanced cancer and lymphomas has completed. The document lists the study…
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction [Phase 1]
Phase 1 study of ixabepilone in patients with advanced solid tumors or lymphoma (including liver dysfunction) has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: S0334 Analyzing Chromosomes in Patients With Newly Diagnosed Multiple Myeloma or Other Blood Disease
SWOG's S0334 trial, which analyzes chromosomal abnormalities in patients with newly diagnosed multiple myeloma and other blood diseases, has…
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY [Phase 1, Phase 2]
This update covers an allogeneic bone marrow transplant using matched related or unrelated donors with FluBu conditioning and HiCy (high-dos…
-
CLINICAL_TRIALS trial_result · 2014-12-24Clinical Trial Update: Nutritional Assessment Intervention to Improve Cancer-Related Fatigue [NA]
Clinical trial update on a nutritional assessment intervention intended to improve cancer-related fatigue in patients with leukemia or lymph…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma [Phase 1]
Phase 1 dose-escalation and safety study of the investigational cancer drug E7820 in patients with malignant solid tumors or lymphoma.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma [Phase 1, Phase 2]
This clinical trial update reports results from Phase 1/2 studies of fostamatinib tablets for lymphoma, with the study completed and results…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment [Phase 1]
Phase I study of ChiLob 7/4, a chimeric anti-CD40 monoclonal antibody, in patients with advanced cancers refractory to conventional treatmen…
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy [Phase 1]
Phase 1 safety study of CLT-008 human myeloid progenitor cells after cord blood transplantation for hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support [Phase 1]
A Phase 1 pharmacokinetic study of palifermin in patients receiving radiation therapy and chemotherapy followed by autologous blood stem cel…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Breathing Adapted Radiotherapy for Mediastinal Lymphoma
Completion of a clinical trial evaluating Breathing Adapted Radiotherapy for Mediastinal Lymphoma. The study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant [NA]
A completed clinical trial evaluated adding aprepitant to granisetron and dexamethasone to prevent nausea and vomiting in patients receiving…
-
CLINICAL_TRIALS trial_result · 2014-09-30Clinical Trial Update: Mild-dose IMRT for Early-staged Extranodal Nasal-type NK/T-cell Lymphoma With CR Tumor After GELOX Chemotherapy [Phase 2]
Phase 2 trial update shows mild-dose IMRT after GELOX chemotherapy achieving complete tumor response in early-staged extranodal nasal-type N…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas [Phase 1]
The document reports the completion of a Phase 1 study evaluating GO-203-2C given intravenously in patients with advanced solid tumors (incl…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer [Phase 1]
Phase 1 clinical trial update reporting the completion of a study of EMD 121974 in patients with various locally advanced or metastatic canc…